Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?

Overall survival following hematopoietic cell transplantation (HCT) has improved over the past two decades through better patient selection and advances in HLA typing, supportive care, and infection prophylaxis. Nonetheless, mortality rates are still unsatisfactory and transplant-related mortality r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Hematol Malig Rep
Autores principales: Sucheston-Campbell, Lara E., Clay, Alyssa, McCarthy, Philip L., Zhu, Qianqian, Preus, Leah, Pasquini, Marcelo, Onel, Kenan, Hahn, Theresa
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2015
Materias:
Stem Cell Transplantation (R Maziarz, Section Editor)
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352187/
https://ncbi.nlm.nih.gov/pubmed/25700678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-014-0246-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares